IPO Listed — 29 May 2026
Listing Price: ₹452 (+31.78% vs ₹343)
Q-Line Biotech SME IPO Review
Q-Line Biotech SME IPO has been reviewed by 1 analyst, and the overall consensus is May Apply — carrying a score of 60. Out of the 1 analysts who have covered this IPO, 0 recommend subscribing while 1 advises caution or avoidance — reflecting a mixed view from the analyst community.
The issue is priced in the band of ₹326-343 per share , with a minimum application size of 400 shares (minimum investment of approximately ₹137,200 at the upper band) . Subscription ran from 21 May 2026 to 25 May 2026. As of now, the grey market premium (GMP) for Q-Line Biotech SME IPO is quoting at ₹108 (31%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.
Table of Contents
Recommend Subscribe
Based on 1 analyst reviews
Higher consensus indicates broader analyst agreement.
Analyst Review
Latest IPO Reviews
Frequently Asked Questions
Should I apply for Q-Line Biotech SME IPO?
Based on analyst coverage tracked on this page, the overall verdict for Q-Line Biotech SME IPO is May Apply. Out of 1 analyst who have reviewed this IPO, 0 recommend subscribing. Always cross-check with the full analyst reviews below and consult a SEBI-registered advisor before making any investment decision.
What does the score of 60 mean for Q-Line Biotech SME IPO?
The score of 60 is an aggregate of all analyst ratings tracked for Q-Line Biotech SME IPO. A score in this range reflects mixed views — some analysts are positive while others are cautious. Scroll down to read individual analyst verdicts for more context.
What was the actual listing price of Q-Line Biotech SME IPO?
Q-Line Biotech SME IPO listed on May 29, 2026 at ₹452 , against the issue price of ₹343 — a gain of +31.78% (₹109 per share). View the full GMP history page for day-wise pre-listing trends.
What is the price band and lot size of Q-Line Biotech SME IPO?
Q-Line Biotech SME IPO was priced at ₹326-343 per share. The minimum lot size is 400 shares, making the minimum investment approximately ₹137,200 at the upper end of the price band. Subscription ran from 21 May 2026 to 25 May 2026.
Explore Q-Line Biotech SME IPO Further
Track every stage of this IPO:
Discussion 0
No comments yet
Be the first to share your thoughts!